TY  - GEN
AU  - Sardella,Gennaro
AU  - Calcagno,Simone
AU  - Mancone,Massimo
AU  - Palmirotta,Raffaele
AU  - Lucisano,Luigi
AU  - Canali,Emanuele
AU  - Stio,Rocco Edoardo
AU  - Pennacchi,Mauro
AU  - Di Roma,Angelo
AU  - Benedetti,Giulia
AU  - Guadagni,Fiorella
AU  - Biondi-Zoccai,Giuseppe
AU  - Fedele,Francesco
TI  - Pharmacodynamic effect of switching therapy in patients with high on-treatment platelet reactivity and genotype variation with high clopidogrel Dose versus prasugrel: the RESET GENE trial
SN  - 1941-7632
PY  - 2013///0402
KW  - Aged
KW  - Area Under Curve
KW  - Aryl Hydrocarbon Hydroxylases
KW  - genetics
KW  - Blood Platelets
KW  - drug effects
KW  - Chi-Square Distribution
KW  - Clopidogrel
KW  - Coronary Artery Disease
KW  - blood
KW  - Cross-Over Studies
KW  - Cytochrome P-450 CYP2C19
KW  - Drug Substitution
KW  - Female
KW  - Genotype
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Myocardial Ischemia
KW  - Percutaneous Coronary Intervention
KW  - adverse effects
KW  - Phenotype
KW  - Piperazines
KW  - administration & dosage
KW  - Platelet Aggregation Inhibitors
KW  - Platelet Function Tests
KW  - Prasugrel Hydrochloride
KW  - Prospective Studies
KW  - Purinergic P2Y Receptor Antagonists
KW  - Receptors, Purinergic P2Y12
KW  - Rome
KW  - Thiophenes
KW  - Ticlopidine
KW  - Treatment Outcome
N1  - Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1161/CIRCINTERVENTIONS.112.972463
ER  -